Stat
- Early data from South Africa hints Omicron variant may cause less severe Covid, but more research is needed
- STAT+: Up and down the ladder: The latest comings and goings
- STAT+: Stoke Therapeutics drug, targeting genetic cause of childhood epilepsy, reduces seizure activity
- STAT+: Pharmalittle: FDA plans rapid review of Omicron vaccines and drugs; Califf would keep Woodcock at FDA
- Opinion: In defense of not treating everyone the same
NYT science news
- Dr. Sherif R. Zaki, Acclaimed Disease Detective, Dies at 65
- The Variant Hunters: Inside South Africa’s Effort to Stanch Dangerous Mutations
- How Bat Moms Teach Bat Pups Their Sense of Direction
- Omicron Variant Spreading Twice as Quickly as Delta in South Africa
- Billions for Climate Protection Fuel New Debate: Who Deserves It Most
Fierce Biotech
- IQVIA releases tool to connect nurses, phlebotomists with clinical trial patients in their homes
- FDA clears Insightec's MRI-guided sound wave technology to treat prostate cancer
- Boston Scientific launches trial of modular, leadless pacemaker-defibrillator system
- Hear, hear: Sound Life Sciences wins FDA OK for app that uses sonar to measure breathing
- Gene therapy startup bursts forth from incubation at J&J and F-Prime, graduating with $80M and a Novartis veteran at the helm
Fierce Medical Devices
- FDA clears Insightec's MRI-guided sound wave technology to treat prostate cancer
- Boston Scientific launches trial of modular, leadless pacemaker-defibrillator system
- Hear, hear: Sound Life Sciences wins FDA OK for app that uses sonar to measure breathing
- Biden’s omicron battle plan includes private insurance reimbursement for at-home COVID tests
- BD enters varicose vein treatment market with Venclose buy